S-8 EX-FILING FEES 0001841330 Fees to be Paid N/A 0001841330 1 2026-01-28 2026-01-28 0001841330 2026-01-28 2026-01-28 iso4217:USD xbrli:pure xbrli:shares

Ex-Filing Fees

CALCULATION OF FILING FEE TABLES

S-8

Pasithea Therapeutics Corp.

Table 1: Newly Registered Securities

                                       
Security Type   Security Class Title   Notes   Fee Calculation
Rule
  Amount Registered   Proposed Maximum Offering
Price Per Unit
  Maximum Aggregate Offering Price   Fee Rate   Amount of Registration Fee
                                       
Equity   Common Stock, $0.0001 par value per share   (1)   Other   11,985,779   $ 0.8603   $ 10,311,365.68   0.0001381   $ 1,424.00
                                       
Total Offering Amounts:   $ 10,311,365.68         1,424.00
Total Fee Offsets:               0.00
Net Fee Due:             $ 1,424.00

 

__________________________________________
Offering Note(s)

(1) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of Pasithea Therapeutics Corp.’s (the “Company”) common stock that become issuable under the Company’s 2023 Stock Incentive Plan, as amended, in respect of the securities identified in the above table by reason of any stock dividend, stock split, recapitalization, or other similar transaction effected without the Company’s receipt of consideration that increases the number of the outstanding shares of the Company’s common stock.

Pursuant to Rules 457(c) and (h) under the Securities Act, the proposed maximum offering price per share and the proposed maximum aggregate offering price are estimated for the purpose of calculating the amount of the registration fee and are based on the average of the high and low sales price of the Company’s common stock as reported on the Nasdaq Stock Market on January 26, 2026.

The Company does not have any fee offsets.